| The relationship between polygenic risk scores and cognition in schizophrenia AL Richards, AF Pardiñas, A Frizzati, KE Tansey, AJ Lynham, P Holmans, ... Schizophrenia bulletin 46 (2), 336-344, 2020 | 100 | 2020 |
| Cognitive analysis of schizophrenia risk genes that function as epigenetic regulators of gene expression L Whitton, D Cosgrove, C Clarkson, D Harold, K Kendall, A Richards, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 171 …, 2016 | 50 | 2016 |
| Cognitive characterization of schizophrenia risk variants involved in synaptic transmission: evidence of CACNA1C's role in working memory D Cosgrove, O Mothersill, K Kendall, B Konte, D Harold, I Giegling, ... Neuropsychopharmacology 42 (13), 2612-2622, 2017 | 45 | 2017 |
| MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls D Cosgrove, D Harold, O Mothersill, R Anney, MJ Hill, NJ Bray, ... Translational psychiatry 7 (1), e1012-e1012, 2017 | 45 | 2017 |
| Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation G Donohoe, J Holland, D Mothersill, S McCarthy-Jones, D Cosgrove, ... Psychological medicine 48 (10), 1608-1615, 2018 | 33 | 2018 |
| The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: a collaborative cognitive and neuroimaging genetics project GAM Blokland, EC Del Re, RI Mesholam-Gately, J Jovicich, JW Trampush, ... Schizophrenia research 195, 306-317, 2018 | 22 | 2018 |
| Genes influenced by MEF2C contribute to neurodevelopmental disease via gene expression changes that affect multiple types of cortical excitatory neurons D Cosgrove, L Whitton, L Fahey, P Ó Broin, G Donohoe, DW Morris Human Molecular Genetics 30 (11), 961-970, 2021 | 19 | 2021 |
| Beyond C4: Analysis of the complement gene pathway shows enrichment for IQ in patients with psychotic disorders and healthy controls JF Holland, D Cosgrove, L Whitton, D Harold, A Corvin, M Gill, ... Genes, Brain and Behavior 18 (8), e12602, 2019 | 15 | 2019 |
| Effects of MiR‐137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls D Cosgrove, DO Mothersill, L Whitton, D Harold, S Kelly, L Holleran, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018 | 13 | 2018 |
| Effects of complement gene‐set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controls JF Holland, D Cosgrove, L Whitton, D Harold, A Corvin, M Gill, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 183 …, 2020 | 9 | 2020 |
| WTCCC2 (2018) Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation G Donohoe, J Holland, D Mothersill, S McCarthy-Jones, D Cosgrove, ... Psychol Med 48, 1608-1615, 0 | 7 | |
| Greater number of older siblings is associated with decreased theory of mind ability in psychosis C Murray, D Cosgrove, A Corvin, M Gill, DW Morris, G Donohoe Schizophrenia research 165 (2-3), 247-248, 2015 | 2 | 2015 |
| O51. Beyond C4: Analysis of the Complement Gene Pathway Shows Enrichment for IQ in Patients With Schizophrenia and Healthy Controls J Holland, D Cosgrove, D Harold, L Whitton, A Corvin, M Gill, ... Biological Psychiatry 85 (10), S126-S127, 2019 | | 2019 |
| 21st Meeting of the Irish Society of Human Genetics: Friday 21st September 2018 Croke Park, Dublin D Cosgrove, L Whitton, G Donohoe, D Morris, S Das, B Moran, D Smeets, ... The Ulster Medical Journal 88 (1), 62-77, 2019 | | 2019 |
| SU121GENETIC VARIATION RELATED TO IMMUNE FUNCTION AND SCHIZOPHRENIA RISK: EVIDENCE FOR EFFECTS ON COGNITION G Donohoe, J Holland, D Mothersill, A Corvin, M Gill, D Cosgrove, ... European Neuropsychopharmacology 29, S1331-S1332, 2019 | | 2019 |
| F78GENES INFLUENCED BY MEF2C CONTRIBUTE TO VARIANCE IN COGNITIVE ABILITY IN THE GENERAL POPULATION D Cosgrove, L Whitton, G Donohoe, D Morris European Neuropsychopharmacology 29, S1152, 2019 | | 2019 |
| THE IMMUNE 8: IMPAIRED COGNITION IN SCHIZOPHRENIA RELATED TO GENETIC, ENVIRONMENTAL, AND IMMUNE INTERACTIONS IN IRISH AND UK COHORTS J Holland, D Morris, D Cosgrove, D Harold, OD Mothershill, A Corvin, ... European Neuropsychopharmacology 29, S879-S880, 2019 | | 2019 |
| Genetic Risk Variants Interacting With MIR137: Effects On Cognition, Brain Structure And Brain Function In Patients And Healthy Participants G Donohoe, D Cosgrove, D Motherills, D Harold, S Kelly, L Holleran, ... European Neuropsychopharmacology 29, S729-S730, 2019 | | 2019 |
| SCHIZOPHRENIA SUSCEPTIBILITY GENE CACNA1C ASSOCIATES WITH MICROSTRUCTURE OF FORNIX: A WHITE MATTER BRAIN PHENOTYPE OF SCHIZOPHRENIA WITH FUNCTION RELATED TO MEMORY J Zhao, D Cosgrove, S Kelly, A Corvin, M Gill, D Cannon, C McDonald, ... EUROPEAN NEUROPSYCHOPHARMACOLOGY 27, S343-S343, 2017 | | 2017 |
| Neurocognitive effects of risk variants for psychosis: neuropsychological and neuroimaging studies of variants and pathways D Cosgrove School of Psychology, National University of Ireland, Galway, 2017 | | 2017 |
